Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
NovoCure
(N2VC34.SA) Q2 2026
Earnings
N2VC34.SA
Apr 30
Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-3.08
-2.64
-2.2
-1.76
Details
Expected EPS
-2.5451546712
Actual EPS
-3.080904
Surprise EPS
-0.54
Surprise Percent
-21.05%
Description
NovoCure (N2VC34.SA) has reported earnings of -3.080904 per share for Q2 2026.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login